CN106421324A - Traditional Chinese medicine composition for treating phlegm-stagnation and heat-arthralgia type rheumatic fever - Google Patents
Traditional Chinese medicine composition for treating phlegm-stagnation and heat-arthralgia type rheumatic fever Download PDFInfo
- Publication number
- CN106421324A CN106421324A CN201611131398.8A CN201611131398A CN106421324A CN 106421324 A CN106421324 A CN 106421324A CN 201611131398 A CN201611131398 A CN 201611131398A CN 106421324 A CN106421324 A CN 106421324A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- chinese medicine
- rheumatic fever
- phlegm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000003068 rheumatic fever Diseases 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 title claims abstract description 15
- 239000000203 mixture Substances 0.000 title claims abstract description 8
- 241001148683 Zostera marina Species 0.000 claims abstract description 8
- 208000006820 Arthralgia Diseases 0.000 claims description 33
- 239000008280 blood Substances 0.000 claims description 28
- 230000001047 pyretic Effects 0.000 claims description 24
- 241000195961 Angiopteris Species 0.000 claims description 12
- 241000333599 Silvetia siliquosa Species 0.000 claims description 7
- 241000219095 Vitis Species 0.000 claims description 7
- 240000000218 Cannabis sativa Species 0.000 claims description 6
- 210000000582 Semen Anatomy 0.000 claims description 6
- 235000009392 Vitis Nutrition 0.000 claims description 6
- 239000012567 medical material Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 4
- 240000005389 Glycyrrhiza glabra Species 0.000 abstract description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- 241000032495 Phlegmariurus fordii Species 0.000 abstract description 2
- 240000002779 Cayratia japonica Species 0.000 abstract 1
- 241000206575 Chondrus crispus Species 0.000 abstract 1
- 241000845833 Elatostema lineolatum Species 0.000 abstract 1
- 241001555026 Euphorbia humifusa Species 0.000 abstract 1
- 241001547125 Fritillaria thunbergii Species 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 235000003283 Pachira macrocarpa Nutrition 0.000 abstract 1
- 241000689764 Pilea martinii Species 0.000 abstract 1
- 241000690369 Schisandra lancifolia Species 0.000 abstract 1
- 244000070669 Solanum ferox Species 0.000 abstract 1
- 235000018253 Solanum ferox Nutrition 0.000 abstract 1
- 240000001085 Trapa natans Species 0.000 abstract 1
- 235000014364 Trapa natans Nutrition 0.000 abstract 1
- 240000006330 Vitis davidii Species 0.000 abstract 1
- 235000004286 Vitis davidii Nutrition 0.000 abstract 1
- 235000014063 licorice root Nutrition 0.000 abstract 1
- 235000009165 saligot Nutrition 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 16
- 235000019634 flavors Nutrition 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 14
- 230000002522 swelling Effects 0.000 description 11
- 206010022114 Injury Diseases 0.000 description 10
- 231100000614 Poison Toxicity 0.000 description 10
- 210000004369 Blood Anatomy 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- 210000004072 Lung Anatomy 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 230000001737 promoting Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 230000001225 therapeutic Effects 0.000 description 5
- 210000000214 Mouth Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 230000000414 obstructive Effects 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010067868 Skin mass Diseases 0.000 description 3
- 210000000952 Spleen Anatomy 0.000 description 3
- 210000002784 Stomach Anatomy 0.000 description 3
- 210000002435 Tendons Anatomy 0.000 description 3
- 230000001058 adult Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 230000001717 pathogenic Effects 0.000 description 3
- 201000010874 syndrome Diseases 0.000 description 3
- 210000001015 Abdomen Anatomy 0.000 description 2
- 208000006673 Asthma Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010006451 Bronchitis Diseases 0.000 description 2
- 206010062746 Carditis Diseases 0.000 description 2
- 208000001848 Dysentery Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 210000003414 Extremities Anatomy 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 206010019233 Headache Diseases 0.000 description 2
- 210000004185 Liver Anatomy 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000008128 Pulmonary Tuberculosis Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 206010068760 Ulcers Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 201000004624 dermatitis Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000001976 improved Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000003119 painkilling Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000025627 positive regulation of urine volume Effects 0.000 description 2
- 230000002588 toxic Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 210000001367 Arteries Anatomy 0.000 description 1
- 206010003246 Arthritis Diseases 0.000 description 1
- 206010003402 Arthropod sting Diseases 0.000 description 1
- 241000969468 Athyriaceae Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 210000000481 Breast Anatomy 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 210000003169 Central Nervous System Anatomy 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008748 Chorea Diseases 0.000 description 1
- 208000007451 Chronic Bronchitis Diseases 0.000 description 1
- 210000002808 Connective Tissue Anatomy 0.000 description 1
- 208000006111 Contracture Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010013990 Dysuria Diseases 0.000 description 1
- 208000005679 Eczema Diseases 0.000 description 1
- 206010016286 Febrile disease Diseases 0.000 description 1
- 241001578027 Ficus simplicissima Species 0.000 description 1
- 241000227647 Fucus vesiculosus Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 206010018830 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 210000000554 Iris Anatomy 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001134529 Microsorum dilatatum Species 0.000 description 1
- 206010027599 Migraine Diseases 0.000 description 1
- 208000008085 Migraine Disorders Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000219098 Parthenocissus Species 0.000 description 1
- 241000756999 Potamogetonaceae Species 0.000 description 1
- 206010072736 Rheumatic disease Diseases 0.000 description 1
- 206010039083 Rhinitis Diseases 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 241000758724 Schisandraceae Species 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N Schizandrin Chemical compound data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='300px' height='300px' viewBox='0 0 300 300'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='300.0' height='300.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 137.4,219.7 L 169.4,233.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-30 atom-20 atom-0' d='M 124.5,187.4 L 137.4,219.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 169.4,233.5 L 168.9,268.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-1 atom-3' d='M 169.4,233.5 L 201.7,220.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 201.7,220.6 L 205.8,255.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 201.7,220.6 L 213.0,222.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 213.0,222.3 L 224.3,223.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-3 atom-6' d='M 201.7,220.6 L 215.5,188.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 215.5,188.6 L 202.6,156.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 202.6,156.3 L 230.5,135.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 202.6,147.6 L 222.2,133.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-31 atom-18 atom-7' d='M 170.6,142.5 L 202.6,156.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 230.5,135.4 L 226.4,100.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 226.4,100.8 L 235.1,94.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 235.1,94.4 L 243.7,87.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-9 atom-12' d='M 226.4,100.8 L 194.4,87.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-9 atom-12' d='M 218.9,105.2 L 196.5,95.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 265.8,84.9 L 276.1,89.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 276.1,89.4 L 286.4,93.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 194.4,87.1 L 193.3,77.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 193.3,77.2 L 192.1,67.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-12 atom-15' d='M 194.4,87.1 L 166.5,107.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 201.0,44.6 L 209.6,38.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 209.6,38.1 L 218.3,31.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-15 atom-16' d='M 166.5,107.9 L 156.3,103.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-15 atom-16' d='M 156.3,103.5 L 146.0,99.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-15 atom-18' d='M 166.5,107.9 L 170.6,142.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-15 atom-18' d='M 174.1,112.3 L 176.9,136.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 133.1,82.2 L 131.8,70.9' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 131.8,70.9 L 130.5,59.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-19' d='M 170.6,142.5 L 138.2,155.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-19 atom-20' d='M 138.2,155.4 L 124.5,187.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-19 atom-20' d='M 129.8,157.4 L 120.1,179.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-32 atom-28 atom-19' d='M 117.4,127.5 L 138.2,155.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-20 atom-21' d='M 124.5,187.4 L 89.9,191.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-21 atom-22' d='M 89.9,191.5 L 69.1,163.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-21 atom-22' d='M 92.3,183.1 L 77.8,163.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-22 atom-23' d='M 69.1,163.5 L 57.7,164.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-22 atom-23' d='M 57.7,164.9 L 46.4,166.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-24 atom-22 atom-25' d='M 69.1,163.5 L 82.8,131.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23 atom-23 atom-24' d='M 26.5,157.0 L 20.1,148.3' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23 atom-23 atom-24' d='M 20.1,148.3 L 13.6,139.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-25 atom-25 atom-26' d='M 82.8,131.5 L 77.0,123.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-25 atom-25 atom-26' d='M 77.0,123.8 L 71.2,116.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-27 atom-25 atom-28' d='M 82.8,131.5 L 117.4,127.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-27 atom-25 atom-28' d='M 88.8,137.9 L 113.0,135.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-26 atom-26 atom-27' d='M 50.0,105.0 L 38.7,106.4' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-26 atom-26 atom-27' d='M 38.7,106.4 L 27.4,107.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-28 atom-28 atom-29' d='M 117.4,127.5 L 121.2,118.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-28 atom-28 atom-29' d='M 121.2,118.6 L 125.1,109.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-29 atom-29 atom-30' d='M 123.3,84.8 L 116.8,76.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-29 atom-29 atom-30' d='M 116.8,76.2 L 110.4,67.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='232.0' y='232.6' class='atom-5' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='241.6' y='232.6' class='atom-5' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='250.2' y='87.0' class='atom-10' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='186.2' y='59.5' class='atom-13' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='130.4' y='101.1' class='atom-16' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='30.3' y='174.6' class='atom-23' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='57.8' y='110.6' class='atom-26' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='127.0' y='102.4' class='atom-29' style='font-size:13px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
</svg>
 data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='85px' height='85px' viewBox='0 0 85 85'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='85.0' height='85.0' x='0.0' y='0.0'> </rect>
<path class='bond-0 atom-0 atom-1' d='M 38.4,61.8 L 47.5,65.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-30 atom-20 atom-0' d='M 34.8,52.6 L 38.4,61.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1 atom-1 atom-2' d='M 47.5,65.7 L 47.4,75.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2 atom-1 atom-3' d='M 47.5,65.7 L 56.7,62.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3 atom-3 atom-4' d='M 56.7,62.0 L 57.8,71.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 56.7,62.0 L 60.5,62.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4 atom-3 atom-5' d='M 60.5,62.6 L 64.4,63.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5 atom-3 atom-6' d='M 56.7,62.0 L 60.6,52.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6 atom-6 atom-7' d='M 60.6,52.9 L 56.9,43.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 56.9,43.8 L 64.8,37.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7 atom-7 atom-8' d='M 56.9,41.3 L 62.4,37.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-31 atom-18 atom-7' d='M 47.8,39.9 L 56.9,43.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8 atom-8 atom-9' d='M 64.8,37.9 L 63.7,28.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 63.7,28.1 L 66.6,25.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9 atom-9 atom-10' d='M 66.6,25.9 L 69.5,23.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-9 atom-12' d='M 63.7,28.1 L 54.6,24.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11 atom-9 atom-12' d='M 61.5,29.3 L 55.2,26.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 73.6,23.1 L 77.1,24.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10 atom-10 atom-11' d='M 77.1,24.6 L 80.6,26.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 54.6,24.2 L 54.2,20.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12 atom-12 atom-13' d='M 54.2,20.9 L 53.8,17.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14 atom-12 atom-15' d='M 54.6,24.2 L 46.7,30.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 55.5,12.8 L 58.4,10.7' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13 atom-13 atom-14' d='M 58.4,10.7 L 61.3,8.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-15 atom-16' d='M 46.7,30.1 L 43.2,28.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15 atom-15 atom-16' d='M 43.2,28.6 L 39.7,27.1' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-15 atom-18' d='M 46.7,30.1 L 47.8,39.9' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17 atom-15 atom-18' d='M 48.8,31.3 L 49.6,38.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 37.4,24.1 L 36.9,20.2' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16 atom-16 atom-17' d='M 36.9,20.2 L 36.5,16.4' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18 atom-18 atom-19' d='M 47.8,39.9 L 38.7,43.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-19 atom-20' d='M 38.7,43.5 L 34.8,52.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19 atom-19 atom-20' d='M 36.3,44.1 L 33.5,50.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-32 atom-28 atom-19' d='M 32.8,35.6 L 38.7,43.5' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20 atom-20 atom-21' d='M 34.8,52.6 L 25.0,53.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-21 atom-22' d='M 25.0,53.7 L 19.1,45.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21 atom-21 atom-22' d='M 25.7,51.4 L 21.5,45.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-22 atom-23' d='M 19.1,45.8 L 15.2,46.3' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22 atom-22 atom-23' d='M 15.2,46.3 L 11.3,46.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-24 atom-22 atom-25' d='M 19.1,45.8 L 23.0,36.8' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23 atom-23 atom-24' d='M 7.7,44.9 L 5.6,42.0' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23 atom-23 atom-24' d='M 5.6,42.0 L 3.4,39.1' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-25 atom-25 atom-26' d='M 23.0,36.8 L 21.0,34.2' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-25 atom-25 atom-26' d='M 21.0,34.2 L 19.1,31.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-27 atom-25 atom-28' d='M 23.0,36.8 L 32.8,35.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-27 atom-25 atom-28' d='M 24.7,38.6 L 31.5,37.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-26 atom-26 atom-27' d='M 15.0,29.1 L 11.1,29.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-26 atom-26 atom-27' d='M 11.1,29.6 L 7.3,30.0' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-28 atom-28 atom-29' d='M 32.8,35.6 L 34.0,32.7' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-28 atom-28 atom-29' d='M 34.0,32.7 L 35.3,29.8' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-29 atom-29 atom-30' d='M 35.1,24.5 L 33.0,21.6' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-29 atom-29 atom-30' d='M 33.0,21.6 L 30.8,18.6' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text x='64.6' y='66.4' class='atom-5' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='68.8' y='66.4' class='atom-5' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >H</text>
<text x='69.8' y='25.2' class='atom-10' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='51.6' y='17.4' class='atom-13' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='35.8' y='29.2' class='atom-16' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='7.5' y='50.0' class='atom-23' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='15.3' y='31.9' class='atom-26' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<text x='34.9' y='29.6' class='atom-29' style='font-size:6px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;text-anchor:start;fill:#E84235' >O</text>
<path d='M 37.0,26.8 L 37.0,25.5 L 38.3,25.5 L 38.3,26.8 L 37.0,26.8' style='fill:none;stroke:#FF0000;stroke-width:1.0px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1;' />
</svg>
 C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 240000002686 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010061372 Streptococcal infection Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 210000004304 Subcutaneous Tissue Anatomy 0.000 description 1
- 206010044008 Tonsillitis Diseases 0.000 description 1
- 208000004371 Toothache Diseases 0.000 description 1
- 210000003932 Urinary Bladder Anatomy 0.000 description 1
- 241000159750 Urtica cannabina Species 0.000 description 1
- 210000003462 Veins Anatomy 0.000 description 1
- 231100000611 Venom Toxicity 0.000 description 1
- 210000001048 Venoms Anatomy 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 201000000736 amenorrhea Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001396 anti-anti-diuretic Effects 0.000 description 1
- 230000001174 ascending Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 201000001973 choreatic disease Diseases 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 231100000406 dermatitis Toxicity 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001882 diuretic Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 231100001003 eczema Toxicity 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003419 expectorant Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000002349 favourable Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002949 hemolytic Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000008738 huangbai Substances 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001617 migratory Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000003000 nontoxic Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 244000052769 pathogens Species 0.000 description 1
- 201000007100 pharyngitis Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
Abstract
The invention discloses a traditional Chinese medicine composition for treating phlegm-stagnation and heat-arthralgia type rheumatic fever. The traditional Chinese medicine composition is characterized by being prepared from the following medicinal materials by weight: 6-9 parts of herba of zostera marina, 12-15 parts of bulb of picrarrhiza kurroa royle, 10-15 parts of frond of carrageen, 15-20 parts of herba of Abacopteris triphylla, 10-15 parts of luffah sponge, 6-9 parts of Zhejiang fritillary bulbs, 10-15 parts of Indian nightshade roots, 35-40 parts of herba or root of cayratia japonica, 15-20 parts of stem and root of schisandra lancifolia, 20-25 parts of water chestnut roots, 10-15 parts of herba of pilea martinii, 20-25 parts of stem or root of euphorbia humifusa, 12-15 parts of herba of elatostema lineolatum, 6-9 parts of herba of phlegmariurus fordii, 40-45 parts of vitis davidii roots and 3-6 parts of licorice roots. The traditional Chinese medicine composition, disclosed by the invention, is used for treating the phlegm-stagnation and heat-arthralgia type rheumatic fever and is high in effective rate and reliable in treatment effect, and recurrence does not occur any more after cure.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicine composition for treating phlegm-blood stasis pyretic arthralgia type rheumatic fever.
Background technology
Rheumatic fever is a kind of apyetouses disease of the general connective tissue relevant with A group R hemolytic streptococcal infection,
Heart, joint, central nervous system and subcutaneous tissue can be involved.This onset of disease is to experience wind heat pathogenic factor, temperature poison is subject to, belongs to the traditional Chinese medical science
Categories such as " epidemic febrile diseases ";Migrans general pain, arthralgia belongs to " migratory arthralgia ";Belonging to " beriberoid pyretic arthralgia " acute rheumatic arthritises more;Chronic wind
Belonging to " anemofrigid-damp arthralgia " or " Yu Xue Bi " wet arthritis more;Carditises then belong to " obstruction of heart-QI ".Its typical clinical manifestation is heating, closes
Section inflammation and carditises, erythema iriss, subcutaneous nodule and chorea are also shown in once in a while.At present, the method for the treatment of rheumatic fever mainly has：In
Cure treatment, western medical treatment etc., than larger it is difficult to treating both the principal and secondary aspects of a disease, and Chinese traditional treatment is effective side for western medical treatment side effect
Method, therapeutic effect is reliable.Rheumatic fever and the different times of progression of disease that the traditional Chinese medical science causes according to different reasons, in conjunction with clinical real
Border carries out Coryza Treated by Syndrome Differentiation, and primary disease is divided into：Wind heat numbness type, damp-heat arthralgia type, cold-damp pyretic arthralgia type, phlegm-blood stasis pyretic arthralgia type, deficiency of YIN pyretic arthralgia type,
Blood deficiency pyretic arthralgia type, the earnest numbness type of battalion.At present, Chinese medicine market being treated rheumatic fever has multiple, but is aimed at phlegm-blood stasis pyretic arthralgia type
The Chinese medicine of rheumatic fever is actually rare, and there is treatment time length, the low defect of cure rate.
Content of the invention
The purpose of the present invention aims to provide a kind of Chinese medicine composition treating phlegm-blood stasis pyretic arthralgia type rheumatic fever, suitable by selecting
Medical material and its proportioning, reach the safe and effective purpose curing phlegm-blood stasis pyretic arthralgia type rheumatic fever.
For reaching above-mentioned purpose, the present invention employs the following technical solutions：A kind of Chinese medicine treating phlegm-blood stasis pyretic arthralgia type rheumatic fever
Compositionss, is characterized in that being made up of the medical material of following weight proportion：
Zostera marina 6-9 part, Rhizoma Coptidis 12-15 part, Pelvetia siliquosa Tseng et C. F. Chang 10-15 part, three mark 15-20 parts, Retinervus Luffae Fructuss 10-15 part, Bulbus Fritillariae Thunbergiis
6-9 part, Radix Solani indici 10-15 part, Herba Ipomoeae Cairicae 35-40 part, Herba Schisandrae lancifoliae 15-20 part, Angiopteris magna Ching (Angiopteris majuscula Ching) 20-25 part, to tender 10-15 part always,
Radix seu Caulis Parthenocissi tricuspidatae 20-25 part, Semen Sojae Preparatum seven 12-15 part, muntjac grass 6-9 part, Vitis davidi root 40-45 part, Radix Glycyrrhizae 3-6 part.
In formula, the source of involved medical material and indication are as follows:
Zostera marina【Source】Medicinal material Ji Yuan：Herb for Potamogetonaceae plant Zostera marina【Nature and flavor】Salty in the mouth；Cold in nature【Return through】Bladder
Warp【Indication】Removing heat-phlegm；Hard masses softening and resolving；Diuretic.Main goiter tuberculosis；Hernia abdominal mass；Edema；Tinea pedis.
Rhizoma Coptidis【Source】Medicinal material Ji Yuan：Bulb for liliaceous plant Tibet low-lying area hemp nettle.【Nature and flavor】Bitter；Sweet；It is slightly cold【Function
Cure mainly】Removing heat-phlegm；Removing toxic substances and promoting subsidence of swelling；Hemostasis.Main lung heat cough and asthma；Expectorant Huang matter is thick；Sore, carbuncle and painful swelling；Traumatic hemorrhage.
Pelvetia siliquosa Tseng et C. F. Chang【Source】Medicinal material Ji Yuan：Frond for Fucus Vesiculosus section plant Pelvetia siliquosa Tseng et C. F. Chang.【Nature and flavor】Salty；Great Cold【Function master
Control】Removing heat-phlegm；Hard masses softening and resolving.Main consumptive fever hectic fever due to YIN-deficiency；Phlegm-heat cough；Pulmonary tuberculosis；Goiter；Scrofula.
Three marks【Source】Fern Athyriaceae three plumage crescent Herba pteridii latiusculi Abacopteris triphylla（Sw.）Ching, with
All herbal medicine.【Nature and flavor】Micro-sweet, pungent, put down.【Indication】Dissipate poison detumescence, removing heat-phlegm.Cure mainly venom, traumatic injury,
Eczema, dermatitis, ulcerative carbuncle furuncle and phyma, acute/chronic bronchitis.
Retinervus Luffae Fructuss【Source】Medicinal material Ji Yuan：Vascular bundle for cucurbitaceous plant Fructus Luffae or Fructus Luffae mature fruit difficult to understand.【Nature and flavor】
Bitter in the mouth；Cool in nature；【Return through】Return lung；Liver；Stomach【Indication】Dredge the meridian passage；Removing toxic substances and promoting subsidence of swelling.Main pain in chest and hypochondrium；Rheumatic arthralgia,
Passages through which vital energy circulates contracture, galactostasiss, lung gesture is coughed, carbuncle future sore, his carbuncle.
Bulbus Fritillariae Thunbergii【Source】Medicinal material Ji Yuan：Bulb for liliaceous plant Bulbus Fritillariae Thunbergii.【Nature and flavor】Bitter in the mouth；Cold in nature【Return through】Return
Lung；Heart channel【Indication】Removing heat-phlegm；Sending down the abnormal ascending QI cough-relieving；Mass dissipating and swelling eliminating.Main air heat or phlegm-heat cough；Lung carbuncle pyemesis；Scrofula wart
Tumor；Sore and toxic.
Radix Solani indici【Source】Root for the pale reddish brown eggplant of plant of Solanaceae.Whole year can adopt.【Nature and flavor】Hardship, puts down.【Indication】Heat clearing away
Dehumidifying, removing blood stasis to reduce swelling.Dispelling the wind and dampness pathogens arthralgia pain, eruptive disease is suffered from abdominal pain, headache, toothache, pharyngitis, tonsillitiss, infantile malnutrition, traumatic injury, scrofula.
Herba Ipomoeae Cairicae【Source】Medicinal material Ji Yuan：Root for moraceae plants ficus simplicissima or branch.【Nature and flavor】Sweet；Slight bitter；Mild-natured【Work(
Can cure mainly】Expelling wind and removing dampness；Removing blood stasis to reduce swelling.The wet flaccidity syndrome and arthralgia syndrome of main air；Lumbago and skelalgia；Dysentery；Edema；Leukorrhagia；Scrofula；Traumatic injury；Amenorrhea；
Breast is few.
Herba Schisandrae lancifoliae【Source】Medicinal material Ji Yuan：Ratan for Schisandraceae Plant lanceleaf magnoliavine fruit and root.【Nature and flavor】Slight bitter；
Puckery；Warm in nature【Indication】Blood circulation promoting and blood stasis dispelling；Reducing swelling and alleviating pain.Main traumatic injury；Fracture；Lumbago due to pathogenic wind-dampness.
Angiopteris magna Ching (Angiopteris majuscula Ching)【Source】Medicinal material Ji Yuan：Rhizome for the big Microsorium dilatatum (Bedd.) Sledge of Angiopteridaceae plant.【Nature and flavor】Bitter；Puckery；Cold【Return
Warp】The heart；Lung；Large intestine channel【Indication】Heat-clearing and toxic substances removing；Diuresis damp eliminating；Promoting blood circulation and hemostasis；Stasis-dispelling and pain-killing.Master has loose bowels；Dysentery；Nephritis
Edema；Gastralgia；Pulmonary tuberculosis；Hemoptysis；Metrorrhagia；Treating swelling and pain by traumatic injury；Rheumatalgia.
Arrive always tender【Source】Medicinal material Ji Yuan：Herb for contrayerva great Ye Rhizoma Belamcandae.【Nature and flavor】Light；Cool in nature【Function
Cure mainly】Heat-clearing and toxic substances removing；Stasis-dispelling and pain-killing；Inducing diuresis to remove edema.Main innominate toxic swelling；Injury and bone fracture；Dysuria；Edema.
Radix seu Caulis Parthenocissi tricuspidatae【Source】Medicinal material Ji Yuan：Rattan for vitaceae parthenocissuss or root.【Nature and flavor】Acrid in the mouth；Micro-puckery；Warm in nature
【Return through】Liver Channel【Indication】Wind-expelling pain-stopping；Promoting blood circulation to remove obstruction in the collateral.Main air pain of dampness syndrome；Apoplexy and hemiplegia；Migraine and general headache；Puerperal blood
The stasis of blood；The raw caking of abdomen；Traumatic injury；Carbuncle sore tumefacting virus；Ulcer being unable to heal.
Semen Sojae Preparatum seven【Source】Medicinal material Ji Yuan：Herb for contrayerva narrow leaf Zlatostema involucratum Franch. Et savat..【Nature and flavor】Bitter；Cold in nature【Function
Cure mainly】Promoting blood circulation to remove obstruction in the collateral；Reducing swelling and alleviating pain；Heat-clearing and toxic substances removing.Main air pain of dampness syndrome；Traumatic injury；Fracture；Traumatic hemorrhage；Ulcer sore pain.
Muntjac grass【Source】Medicinal material Ji Yuan：Herb for Huperziaceae plant Phlegmariurus fordii (Bak) Ching-Bak.【Nature and flavor】Bitter；Cool【Function master
Control】Dispelling wind and removing obstruction in the collateral；Reducing swelling and alleviating pain；Heat-clearing and toxic substances removing.Main joint swells and ache；Numb limbs and tense tendons；Traumatic injury；Cough with asthma；Pyretic stranguria；Poisonous snake stings
Wound.
Vitis davidi root【Source】Medicinal material Ji Yuan：Root for vitaceae Vitis davidi.【Nature and flavor】Sweet；Slight bitter；Flat；Nontoxic
【Indication】Dissipating blood stasis removing food stagnancy；Muscles and tendons relaxing to alleviate pain.Main haematemesis；Abdominal distention disease is amassed；Arthralgia；Bones and tendons injury pain.
Radix Glycyrrhizae【Source】This product is the dry root of glycyrrhizic legume, Glycyrrhiza inflata Bat. or Glycyrrhiza glabra L..【Nature and flavor】Sweet, put down.
【Return through】GUIXIN, lung, spleen, stomach.【Indication】Invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, it is in harmonious proportion all
Medicine.For weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, four limbs contraction, carbuncle sore tumefacting virus, abirritant
Thing toxicity, strong.
The clinical manifestation of phlegm-blood stasis pyretic arthralgia type rheumatic fever is joint swelling and pain, and skin generates heat, do not recover for a long time;Or joint becomes
Shape, activity is unfavorable;Or subcutaneous nodule, secretly, body of the tongue color is dark, have indentation for erythema color purple, and tongue fur is thick in vain or HUANGBAI(sic) is alternate and glutinous greasy, arteries and veins
Many stringy and rolling pulse number.The present invention adopt science proportioning, cooperate between each medicine in formula, synergism, made in
Medical instrument has the effects such as reducing phlegm and fever, eliminating blood stasis and smoothing collaterals, and energy effectively treatment phlegm-blood stasis pyretic arthralgia type rheumatic fever, for many years, by suffering to 40
The use of person shows, effective percentage reaches 95%, and therapeutic effect is good, and follow-up after healing is no longer recurred for 1 year.
With reference to clinical laboratory data, beneficial effects of the present invention to be described：
1st, sampling approach
Closely it is diagnosed as many years the patient of phlegm-blood stasis pyretic arthralgia type rheumatic fever from my unit, randomly select 80 patients, wherein, man 46
Example, female 34, it is randomly divided into matched group and treatment group, every group of each 40 people.There was no significant difference for the data such as two groups of ages, and having can
Compare property.
2nd, test method
2.1 matched group patients use phlegm-blood stasis arthralgia pain soup, and by specification is taken, the course for the treatment of 8 weeks.
2.2 treatment groups are administered orally the capsule that the present invention is obtained according to specific embodiment 1, early, middle and late each once.The course for the treatment of 8 weeks.
3rd, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect：
Clinical recovery：The clinical symptoms of phlegm-blood stasis pyretic arthralgia type rheumatic fever, sign disappear；Effective：The clinic of phlegm-blood stasis pyretic arthralgia type rheumatic fever
Symptom, sign are obviously improved；Effectively：The clinical symptoms of phlegm-blood stasis pyretic arthralgia type rheumatic fever, sign all take a favorable turn；Invalid：Phlegm-blood stasis pyretic arthralgia
The clinical symptoms of type rheumatic fever, sign are all not improved or increase.
3.2 treatment statistics are shown in Table 1.
1 liang of group comparitive study of table
As can be seen here, phlegm-blood stasis pyretic arthralgia type rheumatic fever can safely and effectively be treated using the medicine that the prescription of the present invention is obtained.
Specific embodiment
With reference to the example being embodied as, further detailed description is done to the present invention.
Specific embodiment 1
Weigh 6 grams of Zostera marina, 12 grams of Rhizoma Coptidis, 10 grams of Pelvetia siliquosa Tseng et C. F. Chang, three mark 15 grams, 10 grams of Retinervus Luffae Fructuss, 6 grams of Bulbus Fritillariae Thunbergii, Radix Solani indici
10 grams, 35 grams of Herba Ipomoeae Cairicae, 15 grams of Herba Schisandrae lancifoliae, 20 grams of Angiopteris magna Ching (Angiopteris majuscula Ching), to always tender 10 grams, 20 grams of Radix seu Caulis Parthenocissi tricuspidatae, 7 12 grams of Semen Sojae Preparatum, muntjac grass 6
Gram, 40 grams of Vitis davidi root, 3 grams of Radix Glycyrrhizae, plus 8 times amount water, decoct 1.5 hours, filter；Filtering residue adds 6 times amount water, decocts 1 hour, mistake
Filter；Merging filtrate, concentrates, and is dried, and loads capsule shells, obtains final product the capsule meeting 1 day consumption of adult normal.
For treating phlegm-blood stasis pyretic arthralgia type rheumatic fever.Oral, every bu is taken for early, middle and late three times.
Specific embodiment 2
Weigh 8 grams of Zostera marina, 14 grams of Rhizoma Coptidis, 14 grams of Pelvetia siliquosa Tseng et C. F. Chang, three mark 17 grams, 13 grams of Retinervus Luffae Fructuss, 8 grams of Bulbus Fritillariae Thunbergii, Radix Solani indici
14 grams, 37 grams of Herba Ipomoeae Cairicae, 17 grams of Herba Schisandrae lancifoliae, 22 grams of Angiopteris magna Ching (Angiopteris majuscula Ching), to always tender 14 grams, 22 grams of Radix seu Caulis Parthenocissi tricuspidatae, 7 14 grams of Semen Sojae Preparatum, muntjac grass 8
Gram, 42 grams of Vitis davidi root, 5 grams of Radix Glycyrrhizae, plus 8 times amount water, decoct 1.5 hours, filter；Filtering residue adds 6 times amount water, decocts 1 hour, mistake
Filter；Merging filtrate, concentrates, and is dried, and loads capsule shells, obtains final product the capsule meeting 1 day consumption of adult normal.
For treating phlegm-blood stasis pyretic arthralgia type rheumatic fever.Oral, every bu is taken for early, middle and late three times.
Specific embodiment 3
Weigh 9 grams of Zostera marina, 15 grams of Rhizoma Coptidis, 15 grams of Pelvetia siliquosa Tseng et C. F. Chang, three mark 20 grams, 15 grams of Retinervus Luffae Fructuss, 9 grams of Bulbus Fritillariae Thunbergii, Radix Solani indici
15 grams, 40 grams of Herba Ipomoeae Cairicae, 20 grams of Herba Schisandrae lancifoliae, 25 grams of Angiopteris magna Ching (Angiopteris majuscula Ching), to always tender 15 grams, 25 grams of Radix seu Caulis Parthenocissi tricuspidatae, 7 15 grams of Semen Sojae Preparatum, muntjac grass 9
Gram, 45 grams of Vitis davidi root, 6 grams of Radix Glycyrrhizae, plus 8 times amount water, decoct 1.5 hours, filter；Filtering residue adds 6 times amount water, decocts 1 hour, mistake
Filter；Merging filtrate, concentrates, and is dried, and loads capsule shells, obtains final product the capsule meeting 1 day consumption of adult normal.
For treating phlegm-blood stasis pyretic arthralgia type rheumatic fever.Oral, every bu is taken for early, middle and late three times.
Claims (1)
1. a kind of Chinese medicine composition treating phlegm-blood stasis pyretic arthralgia type rheumatic fever, is characterized in that being made up of the medical material of following weight proportion：
Zostera marina 6-9 part, Rhizoma Coptidis 12-15 part, Pelvetia siliquosa Tseng et C. F. Chang 10-15 part, three mark 15-20 parts, Retinervus Luffae Fructuss 10-15 part, Bulbus Fritillariae Thunbergiis
6-9 part, Radix Solani indici 10-15 part, Herba Ipomoeae Cairicae 35-40 part, Herba Schisandrae lancifoliae 15-20 part, Angiopteris magna Ching (Angiopteris majuscula Ching) 20-25 part, to tender 10-15 part always,
Radix seu Caulis Parthenocissi tricuspidatae 20-25 part, Semen Sojae Preparatum seven 12-15 part, muntjac grass 6-9 part, Vitis davidi root 40-45 part, Radix Glycyrrhizae 3-6 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611131398.8A CN106421324A (en) | 2016-12-09 | 2016-12-09 | Traditional Chinese medicine composition for treating phlegm-stagnation and heat-arthralgia type rheumatic fever |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611131398.8A CN106421324A (en) | 2016-12-09 | 2016-12-09 | Traditional Chinese medicine composition for treating phlegm-stagnation and heat-arthralgia type rheumatic fever |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106421324A true CN106421324A (en) | 2017-02-22 |
Family
ID=58217816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611131398.8A Pending CN106421324A (en) | 2016-12-09 | 2016-12-09 | Traditional Chinese medicine composition for treating phlegm-stagnation and heat-arthralgia type rheumatic fever |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106421324A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200020354A (en) * | 2018-08-17 | 2020-02-26 | 경희대학교 산학협력단 | Pharmaceutical composition for preventing or treating inflammatory disease comprising extract of Pilea martinii as effective component |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103041261A (en) * | 2012-12-21 | 2013-04-17 | 孙红梅 | Traditional Chinese medicine composition for treating heat type arthritis |
| CN105687918A (en) * | 2016-04-27 | 2016-06-22 | 王维娜 | Traditional Chinese medicine composition for treating damp-heat type rheumatic fever and preparing method and application of traditional Chinese medicine composition |
-
2016
- 2016-12-09 CN CN201611131398.8A patent/CN106421324A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103041261A (en) * | 2012-12-21 | 2013-04-17 | 孙红梅 | Traditional Chinese medicine composition for treating heat type arthritis |
| CN105687918A (en) * | 2016-04-27 | 2016-06-22 | 王维娜 | Traditional Chinese medicine composition for treating damp-heat type rheumatic fever and preparing method and application of traditional Chinese medicine composition |
Non-Patent Citations (1)
| Title |
|---|
| 苏晓: "《风湿病中西医实用手册》", 31 December 2015, 人民军医出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200020354A (en) * | 2018-08-17 | 2020-02-26 | 경희대학교 산학협력단 | Pharmaceutical composition for preventing or treating inflammatory disease comprising extract of Pilea martinii as effective component |
| KR102117547B1 (en) * | 2018-08-17 | 2020-06-03 | 경희대학교 산학협력단 | Pharmaceutical composition for preventing or treating inflammatory disease comprising extract of Pilea martinii as effective component |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105106797A (en) | Traditional Chinese medicine nursing composition for treating tenosynovitis | |
| CN104474279A (en) | Traditional Chinese medicine for treating stasis-phlegm type breast nodules | |
| CN103520697A (en) | Traditional Chinese medicine for treating qi-yin deficiency syndrome type chest stuffiness and pains | |
| CN106421324A (en) | Traditional Chinese medicine composition for treating phlegm-stagnation and heat-arthralgia type rheumatic fever | |
| CN104758668A (en) | Traditional Chinese medicine composition for treating tympanites with syndrome of accumulation and binding of water-heat | |
| CN105147884A (en) | Traditional Chinese medicinal composition for treating cervical spondylotic radiculopathy with syndrome of deficiency of qi and blood | |
| CN104707009B (en) | A kind of Chinese medicine for the treatment of type of blood-stasis obstructing in the interior anaphylactoid purpura | |
| CN102631660A (en) | Chinese medicament for treating intestinal obstruction | |
| CN105412765A (en) | Traditional Chinese medicine for treating kidney-yang deficiency infertility | |
| CN104906275A (en) | Traditional Chinese medicine composition for treating stasis stomach impairing type chronic gastritis | |
| CN104623389A (en) | Traditional Chinese medicine composition for treating gout caused by wind-cold-dampness arthralgia | |
| CN104689072A (en) | TCM (Traditional Chinese Medicine) composition for treating blood stasis binding and water retention type tympany | |
| CN104474157A (en) | Traditional Chinese medicine for treating painful heel caused by phlegm-accumulation stasis | |
| CN104208218B (en) | A kind of Chinese medicine for the treatment of stagnant heat type amenorrhea | |
| CN102293879A (en) | Chinese medicinal composition for treating rheumatism | |
| CN105311303A (en) | Traditional Chinese medicine for treating wind-cold-dampness blockage type arthritis | |
| CN104689022A (en) | Traditional Chinese medicine composition for treating stasis physique type degenerative osteoarthropathy | |
| CN101905000B (en) | Formula for treating rheumatism, method for preparing pills and medicinal liquor | |
| CN105381240A (en) | Traditional Chinese medicine for treating arthritis caused by deficiency of liver and kidney | |
| CN105412515A (en) | Traditional Chinese medicine for treating convulsive disease caused when channels and collaterals are obstructed by evil | |
| CN106511808A (en) | Traditional Chinese medicine composition for treating cold-dampness pyretic arthralgia type rheumatic fever | |
| CN104815173A (en) | Traditional Chinese medicine composition for treating blood stasis vessel obstruction syndrome ischialgia | |
| CN104983826A (en) | Traditional Chinese medicine composition for treating atherosclerosis obliterans due to qi stagnation and blood stasis | |
| CN106540087A (en) | A kind of Chinese medicine composition for treating the hot numbness type rheumatic fever of the deficiency of Yin | |
| CN105560860A (en) | Traditional Chinese medicine composition for treating calcaneodynia with symptoms of qi stagnancy and blood stasis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C06 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170222 |
|
| WD01 | Invention patent application deemed withdrawn after publication |